Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology
Restrictions on first grants from Horizon Europe highlight ongoing diplomatic disputes
Researchers have shown that artificial intelligence (AI)-driven software can churn out accurate protein structures by the thousands—an advance and is Science’s 2021 Breakthrough of the Year.
A novel computational platform developed by researchers from the University of Pittsburgh School of Medicine identifies top-performing viral vectors that could deliver gene therapies to the retina with maximum efficiency and precision.
Alcon announced plans to acquire glaucoma surgery device maker Ivantis in a $475 million deal.
Cataract surgery is one of the most successful medical procedures performed in the United States, with nearly 4 million Americans choosing to have their cataracts removed every year. While the procedure has a success rate of about 97 percent, it is not uncommon for people to still need glasses after surgery, especially reading glasses.
The year 2021 saw the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, snaring the top spot in the Overall Best Program category.
Mathieu Quinodoz, bioinformatics researcher in our Ophthalmic Genetics Group led by Carlo Rivolta, wins CHF 30 000 to support his project: «Increasing the molecular diagnostic rate of inherited retinal degenerations and other retinal diseases by combining high-throughput sequencing with an extensive analytical pipeline».
Iceland and Norway have formally become associated to Horizon Europe, enabling entities in those two countries to participate in Europe’s €95.5 billion research and innovation programme, under the same conditions as entities from the EU Member States.
The Commission and the European Union Intellectual Property Office commit to closer collaboration on Intellectual Property to support the market uptake of research results
Congratulations! After having won the Swiss OpthAward 2021, Magdalena Renner, Head of the IOB Human Organoid Platform won the first place of the VSY Biotechnology Ophthalmology Star Awards (OSA) 2021.
The Commission and Turkey signed three agreements granting association status to EU programmes for the period 2021-2027
Optimism Health Group, a healthcare investment business, has recently completed the acquisition of VisionCall, the UK's leading provider of eye care services in care homes. The acquisition came in line with Optimism’s plans to expand its footprint in the fast-growing market for healthcare products and clinical services to older people.
earLab Corp. and MellingMedical are teaming up to empower physicians to more effectively diagnose dry eye disease (DED) among veterans. "We are excited to bring osmolarity testing to America's veterans and help support their patient care and therapy decisions," Chris Melling, founder and CEO of MellingMedical, said in a statement.
AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.